Erythrocyte Microparticles Emerge as Cancer Vaccine Adjuvants
A peer reviewed Nature Biomedical Engineering study published online 23 October 2026 identifies ultraviolet-generated autologous erythrocyte microparticles as an adjuvant that promotes dendritic-cell maturation and tumor-antigen-specific cytotoxic T cell activity. Evidence is preclinical, with…
